| 10/2/2026 | Versant Capital Management Inc | 3,722 | $99K | 0.0% | +11.8% | 0.006% | |
| 9/29/2026 | Cim Investment Management Inc. | 12,525 | $352K | 0.1% | +7.4% | 0.022% | |
| 9/9/2026 | Squarepoint Ops LLC | 54,806 | $1.54M | 0.0% | N/A | 0.094% | |
| 9/8/2026 | Arizona State Retirement System | 11,504 | $323K | 0.0% | -17.2% | 0.020% | |
| 8/21/2026 | AXQ Capital LP | 11,584 | $325K | 0.0% | N/A | 0.020% | |
| 8/19/2026 | UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 102,015 | $2.86M | 0.0% | -10.4% | 0.176% | |
| 8/18/2026 | Empowered Funds LLC | 7,829 | $220K | 0.0% | N/A | 0.013% | |
| 8/18/2026 | Jefferies Financial Group Inc. | 11,200 | $314K | 0.0% | -99.0% | 0.019% | |
| 8/18/2026 | Public Employees Retirement System of Ohio | 56,161 | $1.58M | 0.0% | N/A | 0.097% | |
| 8/17/2026 | Bank of America Corp DE | 980,822 | $27.53M | 0.0% | N/A | 1.688% | |
Get the Latest News and Ratings for BL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BlackLine and its competitors with MarketBeat's FREE daily newsletter.
|
| 8/15/2026 | Fund 1 Investments LLC | 125,000 | $3.51M | 0.6% | N/A | 0.215% | |
| 8/15/2026 | Jupiter Topco LLC | 14,569 | $409K | 0.0% | N/A | 0.025% | |
| 8/14/2026 | Legal & General Group Plc | 108,169 | $3.04M | 0.0% | N/A | 0.186% | |
| 8/14/2026 | The Manufacturers Life Insurance Company | 24,870 | $698K | 0.0% | N/A | 0.043% | |
| 8/13/2026 | ICONIQ Capital LLC | 2,087,081 | $58.58M | 1.7% | N/A | 3.591% | |
| 8/13/2026 | P Schoenfeld Asset Management LP | 21,500 | $603.51K | 0.0% | N/A | 0.037% | |
| 8/11/2026 | Tejara Capital Ltd | 239,237 | $6.72M | 2.8% | N/A | 0.412% | |
| 8/7/2026 | Deutsche Bank AG | 55,643 | $1.56M | 0.0% | N/A | 0.095% | |
| 8/6/2026 | State of Wyoming | 26,784 | $752K | 0.1% | N/A | 0.046% | |
| 8/6/2026 | GSA Capital Partners LLP | 7,974 | $224K | 0.0% | N/A | 0.014% | |
| 7/10/2026 | Handelsbanken Fonder AB | 19,900 | $559K | 0.0% | -7.9% | 0.034% | |
| 7/8/2026 | FNY Investment Advisers LLC | 4,220 | $118K | 0.0% | -19.2% | 0.007% | |
| 7/8/2026 | Evanson Financial LLC | 7,350 | $206K | 0.0% | N/A | 0.013% | |
| 7/2/2026 | Versant Capital Management Inc | 3,330 | $93K | 0.0% | +263.1% | 0.006% | |
| 6/3/2026 | Parallel Advisors LLC | 2,030 | $75K | 0.0% | +467.0% | 0.003% | |
| 6/2/2026 | Optiver Holding B.V. | 975 | $36K | 0.0% | +13,828.6% | 0.002% | |
| 5/28/2026 | Lavelle Capital LP | 16,119 | $596K | 0.4% | N/A | 0.027% | |
| 5/26/2026 | Glenmede Trust Co. NA | 27,199 | $1.01M | 0.0% | +20.7% | 0.046% | |
| 5/19/2026 | Cim Investment Management Inc. | 11,660 | $431K | 0.1% | +89.9% | 0.020% | |
| 5/19/2026 | Bank of America Corp DE | 914,813 | $33.85M | 0.0% | -4.1% | 1.560% | |
| 5/18/2026 | California State Teachers Retirement System | 62,541 | $2.31M | 0.0% | +23.0% | 0.107% | |
| 5/18/2026 | Readystate Asset Management LP | 66,080 | $2.45M | 0.1% | -99.3% | 0.113% | |
| 5/18/2026 | Engaged Capital LLC | 1,367,619 | $50.60M | 16.7% | +26.2% | 2.331% | |
| 5/16/2026 | The Manufacturers Life Insurance Company | 22,490 | $832K | 0.0% | -5.2% | 0.038% | |
| 5/16/2026 | Hawk Ridge Capital Management LP | 1,890,823 | $69.96M | 2.5% | +26.3% | 3.223% | |
| 5/16/2026 | Quantinno Capital Management LP | 41,647 | $1.54M | 0.0% | +196.2% | 0.071% | |
| 5/14/2026 | Public Employees Retirement System of Ohio | 115,536 | $4.28M | 0.0% | +7.8% | 0.197% | |
| 5/14/2026 | Keebeck Wealth Management | 8,664 | $321K | 0.0% | +13.5% | 0.015% | |
| 5/14/2026 | Arrowstreet Capital Limited Partnership | 468,519 | $17.34M | 0.0% | N/A | 0.799% | |
| 5/14/2026 | Inceptionr LLC | 19,290 | $714K | 0.2% | N/A | 0.033% | |
FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial (Ad) A NASDAQ-listed biotech just cleared a major regulatory milestone. The FDA has cleared its lead multiple sclerosis therapy, Lucid-MS, to enter Phase 2 clinical trials - the first time it will be tested in patients with progressive MS.
Unlike treatments that suppress the immune system, Lucid-MS is designed to protect myelin, the insulating layer destroyed by the disease. In a pre-clinical mouse model, treatment led to movement recovery including walking.
Independent research projects peak annual sales of up to $5 billion if Phase 2 succeeds. The stock still trades under $5 per share. See why this FDA clearance could be a defining catalyst |
| 5/14/2026 | Sei Investments Co. | 105,267 | $3.90M | 0.0% | -51.1% | 0.179% | |
| 5/14/2026 | State of Wyoming | 10,912 | $404K | 0.0% | +4.7% | 0.019% | |
| 5/13/2026 | First Trust Advisors LP | 616,716 | $22.82M | 0.0% | +34.9% | 1.051% | |
| 5/8/2026 | PNC Financial Services Group Inc. | 1,713 | $63K | 0.0% | -19.8% | 0.003% | |
| 5/7/2026 | Dimensional Fund Advisors LP | 1,063,655 | $39.35M | 0.0% | +20.6% | 1.784% | |
| 5/7/2026 | Parallel Advisors LLC | 2,030 | $75K | 0.0% | +467.0% | 0.003% | |
| 5/7/2026 | Swiss National Bank | 100,000 | $3.70M | 0.0% | -3.6% | 0.168% | |
| 5/5/2026 | Mcmorgan & Co. LLC | 6,000 | $222K | 0.0% | -33.2% | 0.010% | |
| 5/5/2026 | Illinois Municipal Retirement Fund | 24,727 | $915K | 0.0% | -9.8% | 0.041% | |
| 5/4/2026 | Principal Financial Group Inc. | 361,796 | $13.39M | 0.0% | +11.1% | 0.607% | |
| 5/4/2026 | Schwartz Investment Counsel Inc. | 175,000 | $6.48M | 0.2% | -74.6% | 0.294% | |
| 5/4/2026 | Teachers Retirement System of The State of Kentucky | 12,497 | $463K | 0.0% | -3.8% | 0.021% | |
| 4/30/2026 | Granite Investment Partners LLC | 82,990 | $3.07M | 0.2% | +3.3% | 0.139% | |
| 4/27/2026 | New York State Teachers Retirement System | 13,885 | $514K | 0.0% | -11.0% | 0.023% | |
| 4/27/2026 | Leonteq Securities AG | 1,086 | $40K | 0.0% | +1,019.6% | 0.002% | |
| 4/24/2026 | Conestoga Capital Advisors LLC | 1,685,484 | $62.36M | 1.2% | -8.8% | 2.827% | |
| 4/22/2026 | Pictet Asset Management Holding SA | 8,651 | $320K | 0.0% | +12.0% | 0.015% | |
| 4/21/2026 | Wesbanco Bank Inc. | 41,400 | $1.53M | 0.0% | +25.5% | 0.069% | |
| 4/21/2026 | Louisiana State Employees Retirement System | 22,200 | $821K | 0.0% | N/A | 0.037% | |
| 4/21/2026 | Barton Investment Management | 158,644 | $5.87M | 0.7% | -1.0% | 0.266% | |
| 4/20/2026 | Blue Trust Inc. | 7,516 | $278K | 0.0% | +5.0% | 0.013% | |
| 4/16/2026 | SG Americas Securities LLC | 15,275 | $565K | 0.0% | -32.8% | 0.026% | |
| 3/17/2026 | Rockefeller Capital Management L.P. | 5,728 | $317K | 0.0% | +1,225.9% | 0.010% | |
| 2/25/2026 | MidFirst Bank | 2,509 | $139K | 0.0% | N/A | 0.004% | |
| 2/24/2026 | Pacer Advisors Inc. | 2,217 | $123K | 0.0% | -38.6% | 0.004% | |
| 2/23/2026 | Virtu Financial LLC | 3,807 | $210K | 0.0% | N/A | 0.006% | |
| 2/19/2026 | Invesco Ltd. | 226,633 | $12.53M | 0.0% | -1.0% | 0.381% | |
| 2/18/2026 | Mercer Global Advisors Inc. ADV | 3,914 | $216K | 0.0% | N/A | 0.007% | |
| 2/18/2026 | Papamarkou Wellner Asset Management inc. | 6,997 | $387K | 0.2% | -31.7% | 0.012% | |
| 2/18/2026 | State of Tennessee Department of Treasury | 11,561 | $639K | 0.0% | -7.3% | 0.019% | |
| 2/18/2026 | Empowered Funds LLC | 5,820 | $322K | 0.0% | -63.8% | 0.010% | |
| 2/18/2026 | Susquehanna Portfolio Strategies LLC | 21,748 | $1.20M | 0.0% | -17.9% | 0.037% | |
| 2/18/2026 | Tudor Investment Corp ET AL | 73,273 | $4.05M | 0.0% | N/A | 0.123% | |
| 2/18/2026 | Susquehanna Fundamental Investments LLC | 112,010 | $6.19M | 0.2% | +1,966.6% | 0.188% | |
| 2/18/2026 | Potrero Capital Research LLC | 370,557 | $20.49M | 6.9% | N/A | 0.623% | |
| 2/18/2026 | Governors Lane LP | 118,602 | $6.56M | 0.4% | N/A | 0.199% | |
| 2/18/2026 | First Manhattan CO. LLC. | 2,428,604 | $134.28M | 0.4% | +16.3% | 4.083% | |
| 2/18/2026 | Cinctive Capital Management LP | 199,544 | $11.03M | 0.6% | +30.5% | 0.335% | |
| 2/18/2026 | Boothbay Fund Management LLC | 4,555 | $252K | 0.0% | +8.4% | 0.008% | |
| 2/18/2026 | Ananym Capital Management LP | 253,482 | $14.02M | 5.8% | -42.7% | 0.426% | |
| 2/17/2026 | Nexpoint Asset Management L.P. | 35,450 | $1.96M | 0.1% | N/A | 0.060% | |
| 2/17/2026 | Hawk Ridge Capital Management LP | 1,497,631 | $82.80M | 3.8% | -9.1% | 2.517% | |
| 2/17/2026 | AQR Capital Management LLC | 12,409 | $686K | 0.0% | +20.5% | 0.021% | |
| 2/17/2026 | Abel Hall LLC | 4,334 | $240K | 0.1% | N/A | 0.007% | |
| 2/17/2026 | Westerly Capital Management LLC | 90,000 | $4.98M | 1.1% | N/A | 0.151% | |
| 2/17/2026 | Engaged Capital LLC | 1,083,619 | $59.91M | 15.3% | +138.8% | 1.822% | |
| 2/17/2026 | Price T Rowe Associates Inc. MD | 262,811 | $14.53M | 0.0% | -60.3% | 0.442% | |
| 2/17/2026 | Public Employees Retirement System of Ohio | 107,177 | $5.93M | 0.0% | -3.1% | 0.180% | |
| 2/17/2026 | Captrust Financial Advisors | 5,059 | $280K | 0.0% | -54.9% | 0.009% | |
| 2/17/2026 | Blair William & Co. IL | 85,023 | $4.70M | 0.0% | +2.2% | 0.143% | |
FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial (Ad) A NASDAQ-listed biotech just cleared a major regulatory milestone. The FDA has cleared its lead multiple sclerosis therapy, Lucid-MS, to enter Phase 2 clinical trials - the first time it will be tested in patients with progressive MS.
Unlike treatments that suppress the immune system, Lucid-MS is designed to protect myelin, the insulating layer destroyed by the disease. In a pre-clinical mouse model, treatment led to movement recovery including walking.
Independent research projects peak annual sales of up to $5 billion if Phase 2 succeeds. The stock still trades under $5 per share. See why this FDA clearance could be a defining catalyst |
| 2/16/2026 | Barclays PLC | 472,010 | $26.10M | 0.0% | +4.2% | 0.793% | |
| 2/16/2026 | Bridge City Capital LLC | 30,996 | $1.71M | 0.5% | -13.9% | 0.052% | |
| 2/16/2026 | Bullseye Asset Management LLC | 69,042 | $3.82M | 2.1% | +7.8% | 0.116% | |
| 2/16/2026 | Atlas Capital Advisors Inc. | 4,655 | $257K | 0.0% | N/A | 0.008% | |
| 2/13/2026 | Kestra Advisory Services LLC | 504 | $28K | 0.0% | N/A | 0.001% | |
| 2/13/2026 | Marshall Wace LLP | 8,650 | $478K | 0.0% | -88.7% | 0.015% | |
| 2/13/2026 | The Manufacturers Life Insurance Company | 23,725 | $1.31M | 0.0% | -6.8% | 0.040% | |
| 2/13/2026 | PSquared Asset Management AG | 304,576 | $16.84M | 7.9% | N/A | 0.512% | |
| 2/13/2026 | Soros Fund Management LLC | 75,000 | $4.15M | 0.0% | N/A | 0.126% | |
| 2/13/2026 | CANADA LIFE ASSURANCE Co | 109,687 | $6.06M | 0.0% | -11.5% | 0.184% | |